
    
      Eligible patients will be informed about the possibility of participating in the clinical
      trial in the beginning of treatment and on the day ET, a signed consent form will be
      collected from those recipients who confirmed their participation. These patients will be
      randomized immediately before the ET procedure by sequentially numbered, opaque, sealed
      envelopes
    
  